| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |